AI experts are increasingly afraid of what they’re creating
By Kelsey Piper,
Vox
| 11. 28. 2022
In 2018 at the World Economic Forum in Davos, Google CEO Sundar Pichai had something to say: “AI is probably the most important thing humanity has ever worked on. I think of it as something more profound than electricity or fire.” Pichai’s comment was met with a healthy dose of skepticism. But nearly five years later, it’s looking more and more prescient.
AI translation is now so advanced that it’s on the brink of obviating language barriers on the internet among the most widely spoken languages. College professors are tearing their hair out because AI text generators can now write essays as well as your typical undergraduate — making it easy to cheat in a way no plagiarism detector can catch. AI-generated artwork is even winning state fairs. A new tool called Copilot uses machine learning to predict and complete lines of computer code, bringing the possibility of an AI system that could write itself one step closer. DeepMind’s AlphaFold system, which uses AI to predict the 3D structure of just about every protein in existence, was so...
Related Articles
Not the species, certainly, but the Institute of that name, which was founded by transhumanist philosopher Nick Bostrom in 2005 as a research group at Oxford University. According to a recently posted Final Report, its goal was “to pursue the big questions in a transdisciplinary way” by pulling together “researchers from disciplines such as philosophy, computer science, mathematics, and economics.” This evolved before long into the study and promotion of “effective altruism” and “longtermism” as...
By Tristan Manalac, BioSpace | 04.02.2024
Verve Therapeutics has suspended enrollment in the Phase Ib Heart-1 study evaluating its lead gene editing program VERVE-101 following a serious adverse event, the company announced Tuesday.
A patient, who received a 0.45-mg/kg dose of VERVE-101, developed a grade 3...
By Timnit Gebru and Émile P. Torres, First Monday | 04.14.2024
The stated goal of many organizations in the field of artificial intelligence (AI) is to develop artificial general intelligence (AGI), an imagined system with more intelligence than anything we have ever seen. Without seriously questioning whether such a system can...
By Harold Brubaker, The Philadelphia Inquirer | 04.04.2024
Acompany started by University of Pennsylvania scientist Jim Wilson has received FDA approval to test a form of gene editing in infants for the first time in the United States, the company said Thursday.
The Plymouth Meeting company, iECURE, is...